Nautilus Bio Ownership 2024 | Who Owns Nautilus Bio Now?
Institutional Ownership
51.14%
Insider Ownership
33.51%
Retail Ownership
15.35%
Institutional Holders
76.00
Nautilus Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AH CAPITAL MANAGEMENT, L.L.C. | 14.11% | 3.52% | 17,653,917 | - | - | 41,310,166 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 10.06% | 0.70% | 12,594,211 | - | - | 29,470,453 | Jun 30, 2024 |
| CERCANO MANAGEMENT LLC | 5.73% | 0.45% | 7,172,985 | - | - | 16,784,785 | Jun 30, 2024 |
| MADRONA VENTURE GROUP, LLC | 4.81% | 15.03% | 6,020,770 | - | - | 14,089,000 | Jun 30, 2024 |
| BLACKROCK INC. | 3.06% | 0.00% | 3,827,577 | 95,773 | 2.57% | 8,956,529 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.18% | 0.00% | 2,723,596 | -135,806 | -4.75% | 6,373,214 | Jun 30, 2024 |
| COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 1.76% | 0.18% | 2,207,620 | 1 | - | 5,165,831 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.60% | 0.51% | 2,000,000 | - | - | 4,680,000 | Jun 30, 2024 |
| AMAZON COM INC | 1.16% | 0.14% | 1,457,055 | - | - | 3,409,509 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.91% | 0.00% | 1,134,731 | 27,780 | 2.51% | 2,655,583 | Jun 30, 2024 |
| STATE STREET CORP | 0.75% | 0.00% | 941,238 | 3,190 | 0.34% | 2,202,497,000 | Jun 30, 2024 |
| TIKVAH MANAGEMENT LLC | 0.58% | 0.55% | 726,895 | - | - | 1,700,934 | Jun 30, 2024 |
| CLARIUS GROUP, LLC | 0.51% | 0.11% | 636,532 | 16,661 | 2.69% | 1,489,485 | Jun 30, 2024 |
| ARCHPOINT INVESTORS | 0.49% | 0.54% | 614,271 | 614,271 | 100.00% | 1,437,394 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.46% | 0.00% | 574,844 | 94,908 | 19.78% | 1,344,705 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.40% | 0.00% | 496,370 | -17,906 | -3.48% | 1,161,506,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.35% | 0.01% | 441,018 | - | - | 1,031,982 | Jun 30, 2024 |
| MORGAN STANLEY | 0.26% | 0.00% | 321,560 | -85,031 | -20.91% | 752,451 | Jun 30, 2024 |
| SENTINEL TRUST CO LBA | 0.25% | 0.09% | 315,000 | 5,000 | 1.61% | 737,000 | Jun 30, 2024 |
| WEXFORD CAPITAL LP | 0.17% | 0.12% | 208,350 | 49,249 | 30.95% | 487,539 | Jun 30, 2024 |
Nautilus Bio's largest institutional shareholder is AH CAPITAL MANAGEMENT, L.L.C., holding 14.11% of the company's total share outstanding, currently valued at $41.31M. The top 10 institutional shareholders own together 45.38% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MADRONA VENTURE GROUP, LLC | 4.81% | 15.03% | 6,020,770 | - | - | 14,089,000 | Jun 30, 2024 |
| AH CAPITAL MANAGEMENT, L.L.C. | 14.11% | 3.52% | 17,653,917 | - | - | 41,310,166 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 10.06% | 0.70% | 12,594,211 | - | - | 29,470,453 | Jun 30, 2024 |
| TIKVAH MANAGEMENT LLC | 0.58% | 0.55% | 726,895 | - | - | 1,700,934 | Jun 30, 2024 |
| ARCHPOINT INVESTORS | 0.49% | 0.54% | 614,271 | 614,271 | 100.00% | 1,437,394 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.60% | 0.51% | 2,000,000 | - | - | 4,680,000 | Jun 30, 2024 |
| CERCANO MANAGEMENT LLC | 5.73% | 0.45% | 7,172,985 | - | - | 16,784,785 | Jun 30, 2024 |
| HILLMAN CO | 0.16% | 0.22% | 200,000 | - | - | 468,000 | Jun 30, 2024 |
| COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 1.76% | 0.18% | 2,207,620 | 1 | - | 5,165,831 | Jun 30, 2024 |
| AMAZON COM INC | 1.16% | 0.14% | 1,457,055 | - | - | 3,409,509 | Jun 30, 2024 |
| WEXFORD CAPITAL LP | 0.17% | 0.12% | 208,350 | 49,249 | 30.95% | 487,539 | Jun 30, 2024 |
| CLARIUS GROUP, LLC | 0.51% | 0.11% | 636,532 | 16,661 | 2.69% | 1,489,485 | Jun 30, 2024 |
| SENTINEL TRUST CO LBA | 0.25% | 0.09% | 315,000 | 5,000 | 1.61% | 737,000 | Jun 30, 2024 |
| VANGUARD CAPITAL WEALTH ADVISORS | 0.03% | 0.06% | 35,000 | -1,500 | -4.11% | 81,900 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.01% | 0.02% | 17,793 | 17,793 | 100.00% | 41,636 | Jun 30, 2024 |
| PRESIDIO CAPITAL MANAGEMENT, LLC | 0.01% | 0.02% | 10,000 | - | - | 23,400 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.13% | 0.01% | 164,073 | -4,911 | -2.91% | 383,931 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.35% | 0.01% | 441,018 | - | - | 1,031,982 | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.01% | 0.00% | 14,717 | -9,359 | -38.87% | 34,438 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.00% | 23,916 | 23,916 | 100.00% | 55,963 | Jun 30, 2024 |
The largest Nautilus Bio shareholder by % of total assets is MADRONA VENTURE GROUP, LLC. The company owns 6.02M shares of Nautilus Bio (NAUT), representing 15.03% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCHPOINT INVESTORS | 0.49% | 0.54% | 614,271 | 614,271 | 100.00% | 1,437,394 | Jun 30, 2024 |
| BLACKROCK INC. | 3.06% | 0.00% | 3,827,577 | 95,773 | 2.57% | 8,956,529 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.46% | 0.00% | 574,844 | 94,908 | 19.78% | 1,344,705 | Jun 30, 2024 |
| WEXFORD CAPITAL LP | 0.17% | 0.12% | 208,350 | 49,249 | 30.95% | 487,539 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 0.04% | 0.00% | 45,350 | 45,350 | 100.00% | 106,119 | Jun 30, 2024 |
| BADGLEY PHELPS WEALTH MANAGERS, LLC | 0.02% | 0.00% | 30,000 | 30,000 | 100.00% | 70,200 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.91% | 0.00% | 1,134,731 | 27,780 | 2.51% | 2,655,583 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 26,211 | 26,211 | 100.00% | 61,334 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 26,032 | 26,032 | 100.00% | 60,915 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.00% | 23,916 | 23,916 | 100.00% | 55,963 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.07% | - | 82,889 | 19,853 | 31.49% | 193,960 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.01% | 0.02% | 17,793 | 17,793 | 100.00% | 41,636 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.02% | - | 26,708 | 16,993 | 174.92% | 62,497 | Jun 30, 2024 |
| CLARIUS GROUP, LLC | 0.51% | 0.11% | 636,532 | 16,661 | 2.69% | 1,489,485 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | 0.00% | 140,100 | 14,100 | 11.19% | 327,834 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 10,338 | 6,432 | 164.67% | 24,191 | Jun 30, 2024 |
| SENTINEL TRUST CO LBA | 0.25% | 0.09% | 315,000 | 5,000 | 1.61% | 737,000 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 5,541 | 4,375 | 375.21% | 13,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.02% | - | 20,760 | 4,290 | 26.05% | 48,578 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | - | 3,740 | 3,740 | 100.00% | 8,527 | Jun 30, 2024 |
As of Jun 30 2024, Nautilus Bio's largest institutional buyer is ARCHPOINT INVESTORS. The company purchased 614.27K stocks of NAUT, valued at $1.44M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 2.18% | 0.00% | 2,723,596 | -135,806 | -4.75% | 6,373,214 | Jun 30, 2024 |
| MORGAN STANLEY | 0.26% | 0.00% | 321,560 | -85,031 | -20.91% | 752,451 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 20,153 | -31,434 | -60.93% | 47,158 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 37,617 | -26,384 | -41.22% | 88,023 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -24,880 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -20,637 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,209 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | - | 59,115 | -17,979 | -23.32% | 139,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.40% | 0.00% | 496,370 | -17,906 | -3.48% | 1,161,506,000 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -11,594 | -100.00% | - | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.01% | 0.00% | 14,717 | -9,359 | -38.87% | 34,438 | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 12,758 | -8,225 | -39.20% | 29,853 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | - | 17,468 | -8,066 | -31.59% | 40,526 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.01% | - | 13,096 | -4,921 | -27.31% | 30,645 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | 0.13% | 0.01% | 164,073 | -4,911 | -2.91% | 383,931 | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | 0.01% | 0.00% | 14,494 | -3,344 | -18.75% | 33,917 | Jun 30, 2024 |
| INVESCO LTD. | 0.02% | - | 21,245 | -1,817 | -7.88% | 49,713 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 3,530 | -1,545 | -30.44% | 8,260 | Jun 30, 2024 |
| VANGUARD CAPITAL WEALTH ADVISORS | 0.03% | 0.06% | 35,000 | -1,500 | -4.11% | 81,900 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.06% | 0.00% | 74,615 | -243 | -0.32% | 174,589 | Jun 30, 2024 |
As of Jun 30 2024, Nautilus Bio's biggest institutional seller is VANGUARD GROUP INC. The company sold -0.14M shares of NAUT, valued at $6.37M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARCHPOINT INVESTORS | 0.49% | 0.54% | 614,271 | 614,271 | 100.00% | 1,437,394 | Jun 30, 2024 |
| CI PRIVATE WEALTH, LLC | 0.04% | 0.00% | 45,350 | 45,350 | 100.00% | 106,119 | Jun 30, 2024 |
| BADGLEY PHELPS WEALTH MANAGERS, LLC | 0.02% | 0.00% | 30,000 | 30,000 | 100.00% | 70,200 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 26,211 | 26,211 | 100.00% | 61,334 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 26,032 | 26,032 | 100.00% | 60,915 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.00% | 23,916 | 23,916 | 100.00% | 55,963 | Jun 30, 2024 |
| PALUMBO WEALTH MANAGEMENT LLC | 0.01% | 0.02% | 17,793 | 17,793 | 100.00% | 41,636 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | - | 3,740 | 3,740 | 100.00% | 8,527 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 243 | 243 | 100.00% | 1,000 | Jun 30, 2024 |
Nautilus Bio's largest new institutional shareholder by number of shares is ARCHPOINT INVESTORS, purchased 614.27K shares, valued at $1.44M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -24,880 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -20,637 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,209 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -11,594 | -100.00% | - | Jun 30, 2024 |
Nautilus Bio's largest sold out institutional shareholder by shares sold is AMERICAN INTERNATIONAL GROUP, INC., sold -24.88K shares, valued at -, as of undefined.
Nautilus Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.12% | 314,366 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 16,560 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 405,900 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 17,600 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 589,164 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 38,800 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 86,024 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,810 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,412,725 | -647,589 | -21.16% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 136,354 | -9,124 | -6.27% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 500,486 | 26,722 | 5.64% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,575 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 35,652 | -2,116 | -5.60% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 14,061 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 9,367 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,816 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 87,680 | -19,911 | -18.51% | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,944 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 18,017 | -3,409 | -15.91% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 126,929 | 674 | 0.53% | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 280,198 | 79,417 | 39.55% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 16,300 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,135 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,273 | 622 | 23.46% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,307,068 | -221,743 | -8.77% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 221,646 | 24,669 | 12.52% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 460 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 43,971 | 3,642 | 9.03% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 100,762 | -9,576 | -8.68% | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 8,560 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 19,374 | -78 | -0.40% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 16,734 | 2,246 | 15.50% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,320 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 228 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,600 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 163,179 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 308,716 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 392 | -33 | -7.76% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,290 | -139 | -3.14% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,084 | -466 | -6.17% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,672 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 30 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 25,317 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 17,836 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 47,021 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 5,720 | -23 | -0.40% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 885 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,289 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 239 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,246 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 3,320 | 1,116 | 50.64% | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 37,024 | -1,583 | -4.10% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 33,663 | -781 | -2.27% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 21,857 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 163 | 163 | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,548 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 6,366 | -1,062 | -14.30% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,013 | 437 | 27.73% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 3,039 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 6,155 | - | - | Feb 29, 2024 |
Nautilus Bio's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 314.37K shares, compromising 0.12% of its total assets.
Nautilus Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 76 | 5.56% |
| 31 Mar, 24 | 72 | -6.49% |
| 31 Dec, 23 | 77 | - |
| 30 Sep, 23 | 77 | - |
| 30 Jun, 23 | 77 | -1.28% |
| 31 Mar, 23 | 78 | -1.27% |
| 31 Dec, 22 | 79 | -4.82% |
| 30 Sep, 22 | 83 | 1.22% |
| 30 Jun, 22 | 82 | -3.53% |
| 31 Mar, 22 | 85 | - |
| 31 Dec, 21 | 85 | 16.44% |
| 30 Sep, 21 | 73 | 23.73% |
| 30 Jun, 21 | 59 | - |
As of 30 Jun 24, 76 institutions are holding Nautilus Bio's shares, representing an increase of 5.56% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 63,999,806 | 1.20% |
| 31 Mar, 24 | 63,240,448 | -0.29% |
| 31 Dec, 23 | 63,425,565 | 40.69% |
| 30 Sep, 23 | 45,082,733 | 0.60% |
| 30 Jun, 23 | 44,814,460 | 0.68% |
| 31 Mar, 23 | 44,510,135 | -3.37% |
| 31 Dec, 22 | 46,064,143 | -18.39% |
| 30 Sep, 22 | 56,442,467 | -1.85% |
| 30 Jun, 22 | 57,503,659 | 2.64% |
| 31 Mar, 22 | 56,024,937 | -5.95% |
| 31 Dec, 21 | 59,567,765 | 45.37% |
| 30 Sep, 21 | 40,975,580 | 4.98% |
| 30 Jun, 21 | 39,031,389 | - |
Nautilus Bio (NAUT) has 64.00M shares outstanding as of 30 Jun 24, up 1.20% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 51.14% | 2.00% |
| 31 Mar, 24 | 50.60% | 1.96% |
| 31 Dec, 23 | 50.77% | 3.88% |
| 30 Sep, 23 | 36.18% | 2.80% |
| 30 Jun, 23 | 35.97% | 2.82% |
| 31 Mar, 23 | 35.73% | 2.62% |
| 31 Dec, 22 | 36.91% | 1.80% |
| 30 Sep, 22 | 45.28% | 2.12% |
| 30 Jun, 22 | 46.19% | 2.28% |
| 31 Mar, 22 | 45.03% | 1.96% |
| 31 Dec, 21 | 47.95% | 4.40% |
| 30 Sep, 21 | 33.01% | 3.34% |
| 30 Jun, 21 | 31.45% | - |
As of 30 Jun 24, Nautilus Bio is held by 51.14% institutional shareholders, representing a 2.00% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 31 | 47.62% |
| 31 Mar, 24 | 21 | -36.36% |
| 31 Dec, 23 | 33 | 6.45% |
| 30 Sep, 23 | 31 | 3.33% |
| 30 Jun, 23 | 30 | -6.25% |
| 31 Mar, 23 | 32 | 6.67% |
| 31 Dec, 22 | 30 | 3.45% |
| 30 Sep, 22 | 29 | -29.27% |
| 30 Jun, 22 | 41 | 10.81% |
| 31 Mar, 22 | 37 | -21.28% |
| 31 Dec, 21 | 47 | 17.50% |
| 30 Sep, 21 | 40 | -31.03% |
| 30 Jun, 21 | 58 | - |
31 institutional shareholders have increased their position in NAUT stock as of 30 Jun 24 compared to 21 in the previous quarter (a 47.62% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -25.00% |
| 31 Mar, 24 | 24 | 9.09% |
| 31 Dec, 23 | 22 | 83.33% |
| 30 Sep, 23 | 12 | -42.86% |
| 30 Jun, 23 | 21 | 31.25% |
| 31 Mar, 23 | 16 | -20.00% |
| 31 Dec, 22 | 20 | -13.04% |
| 30 Sep, 22 | 23 | 35.29% |
| 30 Jun, 22 | 17 | - |
| 31 Mar, 22 | 17 | 30.77% |
| 31 Dec, 21 | 13 | 44.44% |
| 30 Sep, 21 | 9 | - |
| 30 Jun, 21 | - | - |
18 institutional shareholders have reduced their position in NAUT stock as of 30 Jun 24 compared to 24 in the previous quarter (a -25.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 76 | 5.56% | 63,999,806 | 1.20% | 51.14% | 2.00% | 31 | 47.62% | 18 | -25.00% |
| 31 Mar, 24 | 72 | -6.49% | 63,240,448 | -0.29% | 50.60% | 1.96% | 21 | -36.36% | 24 | 9.09% |
| 31 Dec, 23 | 77 | - | 63,425,565 | 40.69% | 50.77% | 3.88% | 33 | 6.45% | 22 | 83.33% |
| 30 Sep, 23 | 77 | - | 45,082,733 | 0.60% | 36.18% | 2.80% | 31 | 3.33% | 12 | -42.86% |
| 30 Jun, 23 | 77 | -1.28% | 44,814,460 | 0.68% | 35.97% | 2.82% | 30 | -6.25% | 21 | 31.25% |
| 31 Mar, 23 | 78 | -1.27% | 44,510,135 | -3.37% | 35.73% | 2.62% | 32 | 6.67% | 16 | -20.00% |
| 31 Dec, 22 | 79 | -4.82% | 46,064,143 | -18.39% | 36.91% | 1.80% | 30 | 3.45% | 20 | -13.04% |
| 30 Sep, 22 | 83 | 1.22% | 56,442,467 | -1.85% | 45.28% | 2.12% | 29 | -29.27% | 23 | 35.29% |
| 30 Jun, 22 | 82 | -3.53% | 57,503,659 | 2.64% | 46.19% | 2.28% | 41 | 10.81% | 17 | - |
| 31 Mar, 22 | 85 | - | 56,024,937 | -5.95% | 45.03% | 1.96% | 37 | -21.28% | 17 | 30.77% |
| 31 Dec, 21 | 85 | 16.44% | 59,567,765 | 45.37% | 47.95% | 4.40% | 47 | 17.50% | 13 | 44.44% |
| 30 Sep, 21 | 73 | 23.73% | 40,975,580 | 4.98% | 33.01% | 3.34% | 40 | -31.03% | 9 | - |
| 30 Jun, 21 | 59 | - | 39,031,389 | - | 31.45% | - | 58 | - | - | - |
Nautilus Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of NAUT was made by Patel Sujal M on Mar 11 2024, buying 12,044 shares at $2.84 per share (worth $34.22K).
Nautilus Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 13 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 8 | - | - |
| Q3 2022 | 9 | 2 | 450.00% |
| Q2 2022 | 19 | 1 | 1900.00% |
| Q1 2022 | 9 | 1 | 900.00% |
| Q4 2021 | 9 | 1 | 900.00% |
| Q3 2021 | 5 | - | - |
| Q2 2021 | 9 | 17 | 52.94% |
| Q3 2020 | 3 | 4 | 75.00% |
| Q3 2003 | - | 13 | - |
13 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Nautilus Bio's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 5 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 8 | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | 9 | - | - |
| Q3 2021 | 5 | - | - |
| Q2 2021 | 4 | - | - |
| Q3 2020 | - | - | - |
| Q3 2003 | - | - | - |
As of Q1 2024, Insider owners conducted 5 open market buy trades and 0 open market sell trades of Nautilus Bio's stocks.
Nautilus Bio Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| DTIL | Precision BioSciences, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| BCAB | BioAtla, Inc. |
| FHTX | Foghorn Therapeutics Inc. |
| IPSC | Century Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| HCWB | HCW Biologics Inc. |
| CCCC | C4 Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| BEAM | Beam Therapeutics Inc. |
| MOLN | Molecular Partners AG |
| FIXX | Q32 Bio Inc. |
| ELYM | Eliem Therapeutics, Inc. |
NAUT Ownership FAQ
Who Owns Nautilus Bio?
Nautilus Bio is owned by institutional shareholders (51.14%), insiders (33.51%), and public (15.35%). The largest institutional shareholder of Nautilus Bio is AH CAPITAL MANAGEMENT, L.L.C. (14.11% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.12% of total shares).
Who are the major institutional shareholders of Nautilus Bio?
Nautilus Bio's major institutional shareholders are AH CAPITAL MANAGEMENT, L.L.C., PERCEPTIVE ADVISORS LLC, CERCANO MANAGEMENT LLC, MADRONA VENTURE GROUP, LLC, and BLACKROCK INC.. The top five shareholders own together 37.77% of the company's share outstanding.
How many Nautilus Bio shareholders are there?
As of Jun 2024, there are 76 institutional shareholders of Nautilus Bio.
What percentage of Nautilus Bio is owned by AH CAPITAL MANAGEMENT, L.L.C?
AH CAPITAL MANAGEMENT, L.L.C owns 17.65M shares of Nautilus Bio, representing 14.11% of the company's total shares outstanding, valued at $41.31M (as of Jun 2024).
What percentage of Nautilus Bio is owned by PERCEPTIVE ADVISORS LLC?
As of Jun 2024, PERCEPTIVE ADVISORS LLC holds 12.59M shares of Nautilus Bio (NAUT), compromising 10.06% of the company, valued at $29.47M.
What percentage of Nautilus Bio is owned by CERCANO MANAGEMENT LLC?
CERCANO MANAGEMENT LLC is the third largest holder of Nautilus Bio. The company owns 7.17M of the company's shares outstanding (worth $16.78M).